In This Section

Newsroom

January 14, 2019
Temple Researchers Identify Long-Sought Activator of Sigma Receptors in Human Cells, Marking Important Advance in Cell Biology

Researchers at the Lewis Katz School of Medicine at Temple University (LKSOM), in collaboration with scientists at the University of Cambridge, show that choline, an essential nutrient that functions in metabolism, is an endogenous activator of sigma-1 receptors, marking an important advance in cell biology.
- VIEW STORY
January 10, 2019
Thomas Jefferson University and Temple University Enter Exclusive Negotiations

Jefferson to pursue purchase of Fox Chase Cancer Center
- VIEW STORY
January 09, 2019
Lewis Katz School of Medicine at Temple University Receives $100,000 Donation from Stop Alzheimer’s Now to Conduct Groundbreaking Study

The new study will test whether inhibition of a specific protein in the brain can stimulate neurogenesis.
- VIEW STORY
January 07, 2019
Temple Awarded 5-year, $3.47 Million NIH Grant to Investigate Evidence-Based Treatment Approach to Prevent Excessive Weight Gain in Pregnancy

Temple will work with WIC to study program focused on low-income, racial/ethnic minorities.
- VIEW STORY
December 19, 2018
Temple Plays Leading Role in FDA Approval of a New Minimally Invasive Endobronchial Treatment for Severe Emphysema

Study is the second this year to lead to FDA approval of a minimally invasive treatment for emphysema.
- VIEW STORY
December 11, 2018
Temple-Led Research Team Traces Pathway to Cardioprotection in Post-Ischemic Heart Failure

A Temple-led research team shows for the first time that blocking GRK2 localization to mitochondria protects heart cells from ischemic injury and death, casting new light on GRK2 as a potential therapeutic target in post-injury heart failure.
- VIEW STORY
December 07, 2018
Major Gift Endows New Katz School of Medicine Chair

Temple named the first David Myers Professor and Chair in Otolaryngology-Head and Neck Surgery thanks to a generous gift from Eugene N. Myers, MED ’60, and his wife, Barbara.
- VIEW STORY
November 20, 2018
Temple Scientists Identify Novel Target for Neuron Regeneration and Functional Recovery in Spinal Cord Injury

The discovery of proteins that serve a central role in neuron regeneration is key to the development of drug therapies that have the potential to help patients regain function in their limbs after spinal cord injury.
- VIEW STORY

Newsroom

Pages